CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway.

CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway.
复制标题

CX3CL1通过Src/FAK信号通路参与乳腺癌脊柱转移

DOI:
10.7150/jca.26497
复制
发表时间:
2018
期刊:
影响因子:
3.9
通讯作者:
Dong J
Dong J
中科院分区:
医学3区
文献类型:
--
作者:
Liang Y;Yi L;Liu P;Jiang L;Wang H;Hu A;Sun C;Dong J

文献摘要

参考文献

被引文献

相似文献

C-X3-C chemokine ligand 1 (CX3CL1) has been shown to be involved in the development of multiple tumors. Our previous study demonstrated that CX3CL1 may be involved in the process of metastasis of various malignant tumors to the spine, including breast cancer, but the molecular mechanism was still unknown. In the present study, we found that the receptor CX3CR1 was overexpressed in the spinal metastases of breast cancer than in para-tumor tissue. In terms of CX3CL1, it was significantly more expressed in normal spinal cancellous bone than in limbs. However, CX3CR1 was not expressed at a high level in every breast cancer cell compared with the human mammary epithelial cell line MCF-10A. In addition, CX3CL1 did promote the migration and invasion abilities of MDA-MB-231 cells. However, CX3CL1 has no obvious effect on cell growth. Furthermore, CX3CL1 induced chemotaxis of tumor cells via the Src/FAK signaling pathway. The migration index enhanced by CX3CL1 was dramatically declined using Bosutinib and PF-00562271, which are the inhibitors of Src and FAK signaling pathways, respectively. Therefore, CX3CL1 in spinal cancellous bone attracts CX3CR1-expressing tumor cells to the spine and enhances their migration and invasion abilities through the Src/FAK signaling pathway.
DOI: 10.1158/1535-7163.mct-08-0126
发表时间: 2008-05-01
影响因子: 5.7
作者:
Vultur, Adina;Buettner, Ralf;Jove, Richard
通讯作者: Jove, Richard
DOI: 10.1182/blood-2011-04-348946
发表时间: 2011-11-24
期刊: BLOOD
影响因子: 20.3
作者:
Kim, Ki-Wook;Vallon-Eberhard, Alexandra;Jung, Steffen
通讯作者: Jung, Steffen
DOI: 10.1016/j.nec.2004.04.018
发表时间: 2004-10-01
影响因子: 2.6
作者:
Perrin, RG;Laxton, AW
通讯作者: Laxton, AW
DOI: 10.1128/mcb.14.3.1680
发表时间: 1994-03-01
影响因子: 5.3
作者:
SCHALLER, MD;HILDEBRAND, JD;PARSONS, JT
通讯作者: PARSONS, JT
DOI: 10.1158/0008-5472.can-12-3828
发表时间: 2013-07-15
期刊: Cancer research
影响因子: 11.2
作者:
Tardáguila M;Mira E;García-Cabezas MA;Feijoo AM;Quintela-Fandino M;Azcoitia I;Lira SA;Mañes S
通讯作者: Mañes S